Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Novo Nordisk A/S: Share repurchase programme

Novo Nordisk A/S
Posted on: 18 Dec 17

Bagsværd, Denmark, 12 March 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), also referred to as the Safe Harbour rules. This programme is part of the overall share repurchase programme of up to DKK 14 billion to be executed during a 12-month period beginning 1 February 2018.

Under the programme initiated 5 February 2018, Novo Nordisk will repurchase B shares for an amount up to DKK 2.5 billion in the period from 6 February 2018 to 30 April 2018. 

Further information

Anne Margrethe Hauge+45 4442 3450
Ken Inchausti (US)+1 609 786 8316
Investors :    
Peter Hugreffe Ankersen+45 3075 9085
Hanna Ögren+45 3079 8519
Anders Mikkelsen+45 3079 4461
Christina Kjær+45 3079 3009
Kasper Veje (US)+1 609 235 8567

Company announcement no 23 / 2018

20181203 Safe Harbour CA_UK

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via GlobeNewswire

Last updated on: 13/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.